The "Sepsis Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product; By Technology; By Pathogen; By Testing Type; By Regions; Segment Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
The global sepsis diagnostics market size is predicted to reach USD 1.03 billion by 2027
The key factors responsible for the market growth include innovations in biomarker-based sepsis diagnosis; growing medical attention towards ill effects of sepsis and its economic burden; and the development of technologically advanced rapid PoC diagnosis systems.
Moreover, the favorable reimburse scenario in developed economies and burgeoning healthcare infrastructure in low and middle-income countries is expected to propel market growth.
The market is fragmented based on product, technology, pathogen, type, and region. In terms of product, the market is segmented into instruments, blood culture media, assay kits and reagents, and software. Based on technology, the market is further bifurcated into microbiology, molecular diagnostics, biomarkers, immunoassays, and flow cytometry. Based on pathogen, the market is classified as bacterial sepsis, fungal sepsis, and others. The type segment is further divided into laboratory testing, and PoC testing.
The blood culture media segment accounted for the largest revenue share of the global market as it is used in maximum cases for diagnosis. However, the kits & reagents market segment is expected to witness fastest growth over the forecast period.
Microbiology technology segment is expected to account for the largest revenue share by the end of 2027 as the technology aids in quantitative identification and detection of microorganisms through culture media tests.
Laboratory testing segment is expected to witness significant growth over the forecast period on account of the increasing number of blood cultures conducted in laboratories across the globe.
North America region is dominating the market, holding a significant market share throughout the forecast period. The presence of major players in the region, industry-academia collaboration, and intellectual capability of the U.S. are major factors responsible for the region's growth.
List of Key Players
Thermo Fisher Scientific
Key Topics Covered:
2. Executive Summary
3. Research Methodology
4. Sepsis Diagnostics Market Insights
4.1. Sepsis Diagnostics - Industry snapshot
4.2. Sepsis Diagnostics Market Dynamics
4.2.1. Drivers and Opportunities
18.104.22.168. Innovations in biomarker based sepsis diagnosis
22.214.171.124. Point of care diagnostic tools
4.2.2. Restraints and Challenges
126.96.36.199. High procurement cost of reagents
4.3. Porter's Five Forces Analysis
4.4. PESTLE Analysis
4.5. Sepsis Diagnostics Market Industry trends
5. Sepsis Diagnostics Market Assessment by Product
5.1. Key Findings
5.2.1. Global Sepsis Diagnostics Market, By Product, 2016-2027 (USD Million)
5.4. Blood Culture Media
5.5. Assay Kits and Reagents
6. Global Sepsis Diagnostics Market, by Technology
6.1. Key Findings
6.2.1. Global Sepsis Diagnostics Market, By Technology, 2016-2027 (USD Million)
6.4. Molecular Diagnostics
6.7. Flow Cytometry
7. Global Sepsis Diagnostics Market, by Pathogen
7.1. Key Findings
7.2.1. Global Sepsis Diagnostics Market, By Pathogen, 2016-2027 (USD Million)
7.3. Bacterial Sepsis
7.3.2. Gram-Positive Bacteria
7.3.3. Gram-Negative Bacteria
7.4. Fungal Sepsis
8. Sepsis Diagnostics Market Assessment by Testing Type
8.1. Key Findings
8.2.1. Global Sepsis Diagnostics Market, By Testing Type, 2016-2027 (USD Million)
8.3. Laboratory Testing
8.4. PoC Testing
9. Sepsis Diagnostics Market Assessment by Geography
9.1. Key findings
9.2.1. Sepsis Diagnostics Market Assessment, By Geography, 2016- 2027 (USD Million)
Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/ptmavv
View source version on businesswire.com: https://www.businesswire.com/news/home/20210226005207/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900